Please ensure Javascript is enabled for purposes of website accessibility
Moderna Stock Quote

Moderna (NASDAQ: MRNA)

Price as of June 6, 2023, 12:04 p.m. ET

You’re reading a free stock page from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Moderna Return vs. S&P

1 Year 5 Year 5 Year Annualized Since IPO
MRNA -6.02% +593%
S&P +4.02% +54.16% +9.04% +62%

Moderna Company Info

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA).

News & Analysis

The Fool has written over 1,200 articles on Moderna.


Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.